In this study, we found that miR-124 directly targets Nur77 and that Nur77 is upregulated in multiple pediatric cancer cell lines, including rhabdomyosarcoma, neuroblastoma, and medulloblastoma cell lines. The gene discussed is NR4A1; the disease is neuroblastoma.